Skip to content

A study of treatment results of the cancer of the eye following different treatment modalities.

Indocyanine green enhanced transpupillary thermotherapy Vs Transpupillary thermotherapy for treatment of thicker tumors in Retinoblastoma- A Randomised Control Trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/10/046696
Enrollment
28
Registered
2022-10-21
Start date
Unknown
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C692- Malignant neoplasm of retina

Interventions

Intervention1: TRANSPUPILLARY THERMOTHERAPY: TRANSPUPILLARY THERMOTHERAPY Intervention2: Transpupillary Thermotherapy: Transpupillary Thermotherapy will be delivered using Laser Indirect Ophthalmoscop

Sponsors

DR RAJENDRA PRASAD CENTRE FOR OPHTHALMIC SCIENCES
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.TUMOR HEIGHT >6MM 2.TUMORS INVOLVING FOVEA 3.ANY MEDIA HAZE PRECLUDING THE VISIBILITY OF TUMOR LIKE VITREOUS HAEMORRHAGE/ VITREOUS SEEDS 4.LARGELY CALCIFIED TUMORS 5.NOT WILLING TO GIVE ONSENT

Exclusion criteria

Exclusion criteria: 1.TUMOR HEIGHT >6MM 2.TUMORS INVOLVING FOVEA 3.ANY MEDIA HAZE PRECLUDING THE VISIBILITY OF TUMOR LIKE VITREOUS HAEMORRHAGE/ VITREOUS SEEDS 4.LARGELY CALCIFIED TUMORS 5.NOT WILLING TO GIVE ONSENT

Design outcomes

Primary

MeasureTime frame
To evaluate if ICG enhanced TTT achieves greater reduction in Tumor height as compared to TTT alone in thick Retinoblastoma.Timepoint: Outcome will be assessed at baseline, 3weeks, 6weeks, 9weeks,12weeks under EUA OR till tumor height of less than 2mm, whichever is achieved earlier.

Secondary

MeasureTime frame
To compare the complication rate between 2 groups.Timepoint: Outcome will be assessed at baseline, 3weeks, 6weeks, 9weeks,12weeks under EUA OR till tumor height of less than 2mm, whichever is achieved earlier.

Countries

India

Contacts

Public ContactIpsita Barman

Dr Rajendra Prasad Centre for Ophthalmic Sciences

dr.rachnameel@gmail.com9999768912

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026